FDA-TRACK NCTR Research Divisions Dashboard

Sign up to receive FDA-TRACK email updates

---

Active Dashboard

Archive Dashboard
 

---

Contents:

• Key Center Director Measures
• Program Measures
  • Division of Biochemical Toxicology
  • Division of Genetic and Molecular Toxicology
  • Division of Microbiology
  • Division of Neurotoxicology
  • Division of Systems Biology
  • Office of Scientific Coordination

• Key Projects
• Completed Program Measures - Research Projects
• Research Glossary

Note: Information is as of May 31, 2012.  The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updating preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.

Key Center Director Measures

I. Outreach Measures

A. Maintain / enhance the collaborations (e.g., FDA Product Centers, government agencies, and industry) and working groups to advance the scientific knowledge base.

1. Total number of collaborations and working groups in the quarter

II. Research Publication Measures

A. Increase the submission of manuscripts accepted for publication in scientific journals.

1. Percentage of manuscripts submitted to scientific journals in the last 12 months which were accepted for publication in the quarter

Go back to the top

Program Measures 

NOTE: As research progresses, approaches and strategies can change including the milestones listed under each project. In instances where research approaches and strategies change and milestones and dates are affected, the revised milestone date will be provided in italics under the original milestone date. 

Division of Biochemical Toxicology

I. Develop risk assessment methods and build biological dose-response models in support of food protection

A. Detection and Characterization of Intentional and Unintentional Toxic Food Contaminants
 
B. Contamination of Human and Animal Food with Melamine and Cyanuric Acid

C. Quantitative Assessments of Acrylamide and Furan

D. Bisphenol A (BPA) Data Gap Analysis

E. Toxic/Carcinogenic Effects of Dietary Supplements and Food Container Materials

Go back to the top

Division of Genetic and Molecular Toxicology

I. Develop risk assessment methods and build biological dose-response models in support of food protection

A. Quantitative Cancer Risk Assessments

 

II. Develop biomarkers to assist in identifying the correlation between an individual's nutrition, genetic profile, health, and susceptibility to chronic disease in support of personalized nutrition and health

A. Develop and Validate Genetic Biomarkers 

 

III. Develop science base for supporting FDA regulatory review of new and emerging technologies

A. New Technologies for Safety Assessments 
 
Go back to the top

Division of Microbiology

I. Develop risk assessment methods and build biological dose-response models in support of food protection

A. Molecular Epidemiology of Bacterial Foodborne Pathogens

 

II. Use new omics technologies and pattern-recognition algorithms to analyze imaging data for early-stage disease diagnosis and to study how an FDA-regulated compound or product interacts with the human body

A. Alternative Approaches to Antibiotic Therapy for the Prevention and Treatment of Bacterial Infections

B. Impact of Antimicrobial Drug Residues on Human Gastrointestinal Microorganisms 

 

V. Develop science base for supporting FDA regulatory review of new and emerging technologies

A. Health Safety Assessment of Coronaviruses Circulating in Different Populations

Go back to the top

Division of Neurotoxicology

I. Use new omics technologies and pattern-recognition algorithms to analyze imaging data for early-stage disease diagnosis and to study how an FDA-regulated compound or product interacts with the human body

A. Mechanisms of Monoamine Neurotoxicity

B. Stress and Mitochondrial Toxicity

Go back to the top

Division of Systems Biology

I. Use new omics technologies and pattern-recognition algorithms to analyze imaging data for early-stage disease diagnosis and to study how an FDA-regulated compound or product interacts with the human body

A. Develop Biomarkers of Toxicity and Disease

Go back to the top

Office of Scientific Coordination

I. Workplace Measures

A. Ensure animal care/diet preparation technical workforce is trained to provide quality animal care to NCTR research animals.

1. Percentage of animal care/diet preparation technical personnel who are American Association for Laboratory Animal Science (AALAS) certified
    

II. Health Monitoring Program Measures

A. Ensure animal health monitoring program is compliant with standard operating procedures (SOP).

1. Number of animal rooms scheduled for sentinel animal surveillance during the month
2. Number of animal rooms where sentinel animal surveillance was conducted during the month

Go back to the top
  

Key Projects

 

New Key Projects are currently in development.

NOTE: As research progresses, approaches and strategies can change including the milestones listed under each project. In instances where research approaches and strategies change and milestones and dates are affected, the revised milestone date will be provided in italics under the original milestone date. 

Go back to the top